All Videos - PainCast

(L) Dr. Stanley Golovac_Percutaneous Lumbar Decompression – Video Hero Slider (1)

Percutaneous Lumbar Decompression

This talk highlights the effectiveness and underutilization of the MILD procedure—now formally known as Percutaneous Interlaminar Lumbar Decompression—in treating lumbar spinal stenosis with neurogenic claudication. With over 110,000 cases and 88% satisfaction, it offers a non-implant, minimally invasive solution targeting the root cause: hypertrophic ligamentum flavum. Dr. Stanley Golovac explains patient identification, imaging, clinical criteria, procedural tools, and outcomes, advocating its earlier use before spacers or surgery. Emphasis is placed on diagnosing correctly, proper coding, anatomy respect during the procedure, and debulking the ligament for significant functional improvement—especially in aging populations.

Watch Now

NEWEST VIDEO

Watch Now

(L) Dr. Ale Ismael Gonzalez Cazares – Visceral Neurolytic Blocks for Cancer Pain – Video Hero Slider

NEWEST VIDEO

Visceral Neurolytic Blocks for Cancer Pain

This presentation addresses cancer-related abdominal and pelvic pain management through interventional procedures targeting sympathetic pathways. Dr. Ale reviews indications for splenic nerve neurolysis and celiac plexus block, especially for upper abdominal malignancies like pancreatic cancer. Current evidence supports these blocks (graded 2B+) for opioid-sparing analgesia, though high-quality studies are limited. Advances include CT-guided and endoscopic approaches, and adjunct use of agents like dexmedetomidine to enhance outcomes. The talk also covers superior hypogastric plexus neurolysis for refractory pelvic pain, detailing approaches, complications, and preventive measures. Emphasis is placed on early integration of these procedures and the need for better evidence to improve cancer pain care.

Watch Now

Watch Now

(L) Society Panel – Video Hero Slider

NEWEST VIDEOS

This panel discussion brings together leaders from numerous pain and neuromodulation societies worldwide to address fragmentation within the field. The conversation highlights the diversity of missions among societies like AAPM, INS, WIP, NANS, LAPS, and various state-level organizations. Each group shares its unique focus—whether it’s global education, advocacy, innovation, or specialized therapy. The panelists explore challenges in coordination, competition for resources, and diluted political voice. Despite differences, there's consensus on the need for collaboration to improve patient care and influence policy. Ideas include shared goals, joint advocacy, educational alignment, and possibly forming coalitions like radiology’s RADPAC model.

Watch Now

Watch Video

Society Panel: Discussing the importance of societies

(L) Dr. Hermant Kalia – Intrathecal Drug Delivery Novel Dosing Parameters – Video Hero Slider

NEWEST VIDEO

Intrathecal Drug Delivery Novel Dosing Parameters

This presentation focuses on precision targeted drug delivery (TDD) for cancer pain management, emphasizing recent advances in dosing strategies and intrathecal pharmacology. Dr. Hermant Kalia highlights three core pillars for improved outcomes: infusion settings, drug chemistry, and CSF flow dynamics. The updated 2024 PACC guidelines provide structured recommendations for medication selection, catheter tip placement, and patient-specific factors, stressing system-based considerations like refill logistics. Zyconotide, initially challenged by side effects, now benefits from innovative approaches such as scheduled or patient-controlled boluses, reduced concentrations, and higher infusion rates to maintain efficacy while minimizing toxicity. Precision TDD is evolving toward individualized, guideline-driven, and optimized dosing paradigms.

Watch Now

Watch Now

(L) Dr. Charles Argoff – Medication Management for Headache – Video Hero Slider

Watch Now

NEWEST VIDEO

Watch Now

Medication Management for Headache

In this insightful talk, Dr. Charles Argoff emphasizes the continued importance of pharmacotherapy in headache and migraine treatment. He critiques outdated perceptions and advocates for open-minded, patient-specific approaches that integrate medication with interventional care. Highlighting advances like CGRP antagonists, gepants, and newer formulations of DHE and triptans, he encourages evidence-based, mechanism-driven treatment. He discusses how treatments like Botox and monoclonal antibodies have transformed chronic migraine care, while cautioning against hubris in assuming we always have the right answers. Ultimately, the talk calls for humility, accurate diagnosis, and thoughtful therapy selection.

Slide

This talk highlights the effectiveness and underutilization of the MILD procedure—now formally known as Percutaneous Interlaminar Lumbar Decompression—in treating lumbar spinal stenosis with neurogenic claudication. With over 110,000 cases and 88% satisfaction, it offers a non-implant, minimally invasive solution targeting the root cause: hypertrophic ligamentum flavum. Dr. Stanley Golovac explains patient identification, imaging, clinical criteria, procedural tools, and outcomes, advocating its earlier use before spacers or surgery. Emphasis is placed on diagnosing correctly, proper coding, anatomy respect during the procedure, and debulking the ligament for significant functional improvement—especially in aging populations.

Percutaneous Lumbar Decompression

Slide

This presentation addresses cancer-related abdominal and pelvic pain managementthrough interventional procedures targeting sympathetic pathways. Dr. Ale reviews indications for splenic nerve neurolysis and celiac plexus block, especially for upper abdominal malignancies like pancreatic cancer. Current evidence supports these blocks (graded 2B+) for opioid-sparing analgesia, though high-quality studies are limited. Advances include CT-guided and endoscopic approaches, and adjunct use of agents like dexmedetomidine to enhance outcomes. The talk also covers superior hypogastric plexus neurolysis for refractory pelvic pain, detailing approaches, complications, and preventive measures. Emphasis is placed on early integration of these procedures and the need for better evidence to improve cancer pain care.

Visceral Neurolytic Blocks for Cancer Pain

Slide

Society Panel:
Discussing the importance of societies

This panel discussion brings together leaders from numerous pain and neuromodulation societies worldwide to address fragmentation within the field. The conversation highlights the diversity of missions among societies like AAPM, INS, WIP, NANS, LAPS, and various state-level organizations. Each group shares its unique focus—whether it’s global education, advocacy, innovation, or specialized therapy. The panelists explore challenges in coordination, competition for resources, and diluted political voice. Despite differences, there's consensus on the need for collaboration to improve patient care and influence policy. Ideas include shared goals, joint advocacy, educational alignment, and possibly forming coalitions like radiology’s RADPAC model.

Slide

This presentation focuses on precision targeted drug delivery (TDD) for cancer pain management, emphasizing recent advances in dosing strategies and intrathecal pharmacology. Dr. Hermant Kalia highlights three core pillars for improved outcomes: infusion settings, drug chemistry, and CSF flow dynamics. The updated 2024 PACC guidelines provide structured recommendations for medication selection, catheter tip placement, and patient-specific factors, stressing system-based considerations like refill logistics. Zyconotide, initially challenged by side effects, now benefits from innovative approaches such as scheduled or patient-controlled boluses, reduced concentrations, and higher infusion rates to maintain efficacy while minimizing toxicity. Precision TDD is evolving toward individualized, guideline-driven, and optimized dosing paradigms.

Intrathecal Drug Delivery Novel Dosing Parameters

Slide

In this insightful talk, Dr. Charles Argoff emphasizes the continued importance of pharmacotherapy in headache and migraine treatment. He critiques outdated perceptions and advocates for open-minded, patient-specific approaches that integrate medication with interventional care. Highlighting advances like CGRP antagonists, gepants, and newer formulations of DHE and triptans, he encourages evidence-based, mechanism-driven treatment. He discusses how treatments like Botox and monoclonal antibodies have transformed chronic migraine care, while cautioning against hubris in assuming we always have the right answers. Ultimately, the talk calls for humility, accurate diagnosis, and thoughtful therapy selection.

Medication Management for Headache

Recent Popular

4 Results found

Videos

Pro

November 15, 2021

Peng – Ultrasound Anatomy, Diagnoses and Procedures of the Shoulder

Dr. Philip Peng discusses ultrasound anatomy, diagnoses, and procedures of the shoulder. He covers a scanning protocol for shoulder examination and interventions for shoulder pain. Scanning is important for getting a good picture of...

$3.75

Pro

November 15, 2021

Kumar – Ultrasound Anatomy, diagnoss and procedures of the elbow joint, wrist and hand

Dr. Pranab Kumar reviews the CIPS exam syllabus and diagnoses of common disorders affecting elbow, wrist, and hand. He also talks about scanning protocols and sono-anatomy with emphasis on common procedures. Different types of...

$3.75

Pro

November 15, 2021

Lam – Sonoanatomy and Guided Procedures of Knee and Ankle

Dr. Stanley Lam talks about sonoanatomy and guided procedure of the knee and ankle in this talk. Dr. Lam describes how talking to the patient is important when conducting an exam. For instance, ask...

$3.75

Pro

André Marques Mansano

November 15, 2021

Mansano – Ultrasound Guided Hip Procedures

Dr. Andre Mansano discusses ultrasound guided hip procedures. Hip pain occurs in approximately 14% of individuals aged 60 years and older. This hip pain can be caused by a variety of problems. Intra-articular injections...

$3.75